In this trial in particular, our hope is to find a new therapy that will benefit patients with MPNST for which we have no known effective medical therapies. Using a combination of drugs that target specific pathways involved in MPNST growth, Dr
Serious safety concerns (immune reactions, cancer risk)
CGRP, when released from the bodies or axonal swellings of stimulated trigeminal neurons, can trigger satellite glial cells within the trigeminal ganglia, as well as microglia and astrocytes in the trigeminal nucleus caudalis
A 2019 meta-analysis noted mixed outcomes in autoimmune thyroid conditions, with some studies showing reduced TPO antibodies and improved TSH control, while others showed minimal clinical benefit
Patients on MAOIs, stimulant medications for ADHD, or decongestants containing phenylephrine face amplified sympathetic overdrive when phentermine is introduced